Brent McLaurin

6.2k citations

24 papers · 1.5k indexed · h-index 18

Internal Medicine top 1%
- Venous Thromboembolism Diagnosis and Management 5
Cardiology and Cardiovascular Medicine top 1%
- Acute Myocardial Infarction Research 15
- Antiplatelet Therapy and Cardiovascular Diseases 9
- Atrial Fibrillation Management and Outcomes 7
- Cardiac Valve Diseases and Treatments 3
Surgery top 5%
- Coronary Interventions and Diagnostics 14
- Heparin-Induced Thrombocytopenia and Thrombosis 2
Radiology, Nuclear Medicine and Imaging top 5%
- Cardiac Imaging and Diagnostics 6
Pulmonary and Respiratory Medicine top 10%

Co-authors: Roxana Mehran Gregg W. Stone David A. Cox A. Michael Lincoff Harvey D. White Michel E. Bertrand Alexandra J. Lansky Steven V. Manoukian
Cited by: Internal Medicine Cardiology and Cardiovascular Medicine Surgery
Partner nations: United States New Zealand France

In The Last Decade

Brent McLaurin

24 papers receiving 1.5k citations

Peers

Countries citing papers authored by Brent McLaurin

Since Specialization

Citations

This map shows the geographic impact of Brent McLaurin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brent McLaurin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brent McLaurin more than expected).

Fields of papers citing papers by Brent McLaurin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brent McLaurin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brent McLaurin. The network helps show where Brent McLaurin may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Brent McLaurin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Brent McLaurin Line = papers co-authored together Brent McLaurin links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Global Approach to High Bleeding Risk Patients With Polymer-Free Drug-Coated Coronary Stents Mitchell W. Krucoff,Philip Urban,Jean‐François Tanguay,Thomas McAndrew,Yiran Zhang,Sunil V. Rao,Marie‐Claude Morice,Matthew J. Price,David J. Cohen,Mohamed Abdel‐Wahab,Shamir R. Mehta,Benjamin Faurie,Brent McLaurin,Corie Diaz,Hans‐Peter Stoll,Stuart Pocock,Martin B. Leon	2020	20
2	First Report of the Resolute Onyx 2.0-mm Zotarolimus-Eluting Stent for the Treatment of Coronary Lesions With Very Small Reference Vessel Diameter Matthew J. Price,Shigeru Saito,Richard Shlofmitz,Douglas Spriggs,Michael Attubato,Brent McLaurin,Alexandra Almonacid,Sandeep Brar,Minglei Liu,Elizabeth Moe,Roxana Mehran	2017	39
3	Bleeding Risk Factors Affecting Warfarin Therapy in the Elderly With Atrial Fibrillation Stan W. Darnell,Stephanie Davis,John J. Whitcomb,Joseph A. Manfredi,Brent McLaurin	2014	10
4	Quantification of the effect of clopidogrel on enzymatic infarct size related to a percutaneous coronary intervention in patients with acute coronary syndromes Sergio Leonardi,Amanda Stebbins,Renato D. Lópes,Yuliya Lokhnygina,Meredith Todd,Deepak L. Bhatt,Gregg W. Stone,A. Michael Lincoff,Harold L. Dauerman,C. Michael Gibson,Harvey D. White,Keyur Parikh,Luis Gruberg,Howard C. Herrmann,Brent McLaurin,Shaun G. Goodman,Kenneth W. Mahaffey	2013	3
5	Outcomes of Patients With Prior Coronary Artery Bypass Grafting and Acute Coronary Syndromes Eugenia Nikolsky,Brent McLaurin,David A. Cox,Steven V. Manoukian,Ke Xu,Roxana Mehran,Gregg W. Stone	2012	27
6	Implications of pre-procedural TIMI flow in patients with non ST-segment elevation acute coronary syndromes undergoing percutaneous coronary revascularization: Insights from the ACUITY trial Giuseppe De Luca,Sorin J. Brener,Roxana Mehran,Alexandra J. Lansky,Brent McLaurin,David A. Cox,Ecaterina Cristea,Martin Fahy,Gregg W. Stone	2012	7
7	A RANDOMIZED COMPARISON OF THE ENDEAVOR DRUG (ABT-578) ELUTING STENT VERSUS TAXUS PACLITAXEL-ELUTING STENT IN DIABETIC PATIENTS: THREE-YEAR OUTCOMES FROM ENDEAVOR IV Ajay J. Kirtane,Rikesh Patel,Charles O’Shaunessy,Brent McLaurin,David E. Kandzari,Martin B. Leon	2010	2
8	Predictive value of C-reactive protein on 30-day and 1-year mortality in acute coronary syndromes: an analysis from the ACUITY trial Adriano Caixeta,Gregg W. Stone,Roxana Mehran,Edwin A. Lee,Brent McLaurin,David A. Cox,Michel E. Bertrand,A. Michael Lincoff,Jeffrey W. Moses,Harvey D. White,E. Magnus Ohman,Tullio Palmerini,George Syros,Christos Kittas,Martin Fahy,W. Craig Hooper,Alexandra J. Lansky,George Dangas	2010	23
9	A Randomized Comparison of the Endeavor Zotarolimus-Eluting Stent Versus the TAXUS Paclitaxel-Eluting Stent in De Novo Native Coronary Lesions Martin B. Leon,Laura Mauri,Jeffrey J. Popma,Donald E. Cutlip,Eugenia Nikolsky,Charles O’Shaughnessy,Paul Overlie,Brent McLaurin,Stuart Solomon,John S. Douglas,Michael W. Ball,Ronald Caputo,Ash Jain,Thaddeus R. Tolleson,Bernard M. Reen,Ajay J. Kirtane,Peter J. Fitzgerald,Kweli P. Thompson,David E. Kandzari	2010	185
10	Impact of Femoral Vascular Closure Devices and Antithrombotic Therapy on Access Site Bleeding in Acute Coronary Syndromes Timothy A. Sanborn,Ramin Ebrahimi,Steven V. Manoukian,Brent McLaurin,David A. Cox,Frederick Feit,Martial Hamon,Roxana Mehran,Gregg W. Stone	2010	68
11	Gastrointestinal Bleeding in Patients With Acute Coronary Syndromes: Incidence, Predictors, and Clinical Implications Eugenia Nikolsky,Gregg W. Stone,Ajay J. Kirtane,George Dangas,Alexandra J. Lansky,Brent McLaurin,A. Michael Lincoff,Frederick Feit,Jeffrey W. Moses,Martin Fahy,Steven V. Manoukian,Harvey D. White,E. Magnus Ohman,Michel E. Bertrand,David A. Cox,Roxana Mehran	2009	143
12	Prognostic Significance of Periprocedural Versus Spontaneously Occurring Myocardial Infarction After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndromes Abhiram Prasad,Bernard J. Gersh,Michel E. Bertrand,A. Michael Lincoff,Jeffrey W. Moses,E. Magnus Ohman,Harvey D. White,Stuart Pocock,Brent McLaurin,David A. Cox,Alexandra J. Lansky,Roxana Mehran,Gregg W. Stone	2009	125
13	Late Safety, Efficacy, and Cost-Effectiveness of a Zotarolimus-Eluting Stent Compared With a Paclitaxel-Eluting Stent in Patients With De Novo Coronary Lesions Martin B. Leon,David E. Kandzari,Eric L. Eisenstein,Kevin J. Anstrom,Laura Mauri,Donald E. Cutlip,Eugenia Nikolsky,Charles O’Shaughnessy,Paul Overlie,Ajay J. Kirtane,Brent McLaurin,Stuart Solomon,John S. Douglas,Jeffrey J. Popma	2009	43
14	Outcomes of Patients with Coronary Artery Perforation Complicating Percutaneous Coronary Intervention and Correlations with the Type of Adjunctive Antithrombotic Therapy: Pooled Analysis from REPLACE‐2, ACUITY, and HORIZONS‐AMI Trials Jacob A. Doll,Eugenia Nikolsky,Gregg W. Stone,Roxana Mehran,A. Michael Lincoff,Adriano Caixeta,Brent McLaurin,Ecaterina Cristea,Martin Fahy,Vijaya Kesanakurthy,Alexandra J. Lansky	2009	33
15	Clinical and Angiographic Outcomes in Diabetics From the ENDEAVOR IV Trial Ajay J. Kirtane,Rikesh Patel,Charles O’Shaughnessy,Paul Overlie,Brent McLaurin,Stuart Solomon,Laura Mauri,Peter J. Fitzgerald,Jeffrey J. Popma,David E. Kandzari,Martin B. Leon	2009	38
16	A Novel Filter-Based Distal Embolic Protection Device for Percutaneous Intervention of Saphenous Vein Graft Lesions Dean J. Kereiakes,Mark Turco,Jeffrey A. Breall,Naim Farhat,Robert L. Feldman,Brent McLaurin,Jeffrey J. Popma,Laura Mauri,Peter Zimetbaum,Joseph M. Massaro,Donald E. Cutlip	2008	23
17	Economic Evaluation of Bivalirudin With or Without Glycoprotein IIb/IIIa Inhibition Versus Heparin With Routine Glycoprotein IIb/IIIa Inhibition for Early Invasive Management of Acute Coronary Syndromes Duane S. Pinto,Gregg W. Stone,Chunxue Shi,Elizabeth S. Dunn,Matthew R. Reynolds,Meghan York,Joshua Walczak,Ronna H. Berezin,Roxana Mehran,Brent McLaurin,David A. Cox,E. Magnus Ohman,A. Michael Lincoff,David J. Cohen	2008	61
18	Safety and Efficacy of Bivalirudin With and Without Glycoprotein IIb/IIIa Inhibitors in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention Harvey D. White,E. Magnus Ohman,A. Michael Lincoff,Michel E. Bertrand,Antonio Colombo,Brent McLaurin,David A. Cox,Stuart Pocock,James A. Ware,Steven V. Manoukian,Alexandra J. Lansky,Roxana Mehran,Jeffrey W. Moses,Gregg W. Stone	2008	55
19	Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trial Gregg W. Stone,Harvey D. White,E. Magnus Ohman,Michel E. Bertrand,A. Michael Lincoff,Brent McLaurin,David A. Cox,Stuart Pocock,James H. Ware,Frederick Feit,Antonio Colombo,Steven V. Manoukian,Alexandra J. Lansky,Roxana Mehran,Jeffrey W. Moses	2007	276
20	Normokinesia Adjacent to Left Ventricular Aneurysm: A Differential Risk for Sudden Cardiac Death Constantine A. Hassapoyannes,Brent McLaurin,Carlton A. Hornung,Kiran Chavda,Dan‐Victor Giurgiutiu	2002	3

About Brent McLaurin

Brent McLaurin is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine and Surgery, having authored 24 papers that have together received 1.5k indexed citations. Recurring topics across this work include Acute Myocardial Infarction Research (15 papers), Coronary Interventions and Diagnostics (14 papers), Antiplatelet Therapy and Cardiovascular Diseases (9 papers), Atrial Fibrillation Management and Outcomes (7 papers), Cardiac Imaging and Diagnostics (6 papers), Venous Thromboembolism Diagnosis and Management (5 papers), Cardiac Valve Diseases and Treatments (3 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (2 papers). The work is most often cited by research in Internal Medicine (345 citations), Cardiology and Cardiovascular Medicine (1.3k citations) and Surgery (974 citations). Brent McLaurin has collaborated with scholars based in United States, New Zealand and France. Frequent co-authors include Roxana Mehran, Gregg W. Stone, David A. Cox, A. Michael Lincoff, Harvey D. White, Michel E. Bertrand, Alexandra J. Lansky, Steven V. Manoukian, Jeffrey W. Moses and Frederick Feit.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact